Clinigen Group, the global pharmaceutical Products and Services company, has signed a distribution agreement with Amgen to supply part of its product portfolio to multiple countries across Africa and Asia.
Under the terms of the distribution agreement, Clinigen will provide physicians and pharmacists in certain territories with access to medicines which are not currently commercially available.
Clinigen will act as the main point of contact for healthcare professionals wanting to access the medicines, managing all elements of the process including order and enquiry management, regulatory compliance, and logistics. The agreement will help support both companies’ missions of increasing access to medicines for patients across the world.
The following products are included in the agreement:
Sam Herbert, Chief Operating Officer, Clinigen, said: “We are pleased to be partnering with Amgen to supply this portfolio of medicines for patients with unmet medical needs. This agreement will help to ensure healthcare professionals can obtain compliant access to critical medicines that are not commercially available in their country.”